UT Health Science Center-San Antonio: Can Alzheimer's Disease Be Delayed Or Stopped Before The Symptoms Begin? A New Clinical Trial Strives To Find Answers
December 02, 2022
December 02, 2022
SAN ANTONIO, Texas, Dec. 2 (TNSjou) -- The University of Texas Health Science Center at San Antonio issued the following news release:
The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, part of The University of Texas Health Science Center at San Antonio, seeks dementia-free volunteers ages 55 to 80 to enroll in a clinical trial of an investigational antibody. The goal of the AHEAD study is to assess whether IV infusions of the antibody (lecanemab) can de . . .
The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, part of The University of Texas Health Science Center at San Antonio, seeks dementia-free volunteers ages 55 to 80 to enroll in a clinical trial of an investigational antibody. The goal of the AHEAD study is to assess whether IV infusions of the antibody (lecanemab) can de . . .